Stephen I. Pelton, MD

Professor, Pediatrics

Stephen Pelton
617.414.7408
670 Albany St Biosquare III

Biography

Stephen I Pelton MD is Professor of Pediatrics and Epidemiology at Boston University School of Medicine and Public Health and Director of Pediatrics Infectious Diseases at Boston Medical Center. Dr Pelton’s interests focus on the effects of recurrent disease and the long term effects of HIV, Hepatitis C and B, and Herpes among other things. Additionally, he organizes numerous clinical trials to discover new approaches to HIV prevention and treatment.

Other Positions

  • Director (Section) of Pediatrics>Infectious Disease, Infectious Diseases, Pediatrics, Boston University School of Medicine
  • Professor, Epidemiology, Boston University School of Public Health
  • Member, Pulmonary Center, Boston University

Education

  • State University of New York at Buffalo, MD
  • Queens College, City University of New York, BA

Publications

  • Published on 1/20/2020

    Yildirim M, Keskinocak P, Pelton S, Pickering L, Yildirim I. Who is at risk of 13-valent conjugated pneumococcal vaccine failure? Vaccine. 2020 Feb 11; 38(7):1671-1677. PMID: 31974018.

    Read at: PubMed
  • Published on 12/18/2019

    Alderson MR, Murphy T, Pelton SI, Novotny LA, Hammitt LL, Kurabi A, Li JD, Thornton RB, Kirkham LS. Panel 8: Vaccines and immunology. Int J Pediatr Otorhinolaryngol. 2020 Mar; 130 Suppl 1:109839. PMID: 31948716.

    Read at: PubMed
  • Published on 9/30/2019

    Pelton SI, Lapidot R, Yildirim I. Invasive Pneumococcal Disease-Not Evenly Shared by All Children. JAMA Pediatr. 2019 Sep 30. PMID: 31566674.

    Read at: PubMed
  • Published on 6/18/2019

    Yildirim I, Pelton SI. Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis. 2019 Jun 18; 69(1):91-92. PMID: 30281070.

    Read at: PubMed
  • Published on 6/10/2019

    Grammatico-Guillon L, Abdurrahim L, Shea K, Astagneau P, Pelton S. Scope of Antibiotic Stewardship Programs in Pediatrics. Clin Pediatr (Phila). 2019 Oct; 58(11-12):1291-1301. PMID: 31179745.

    Read at: PubMed
  • Published on 5/30/2019

    Sings HL, De Wals P, Gessner BD, Isturiz R, Laferriere C, McLaughlin JM, Pelton S, Schmitt HJ, Suaya JA, Jodar L. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies. Clin Infect Dis. 2019 05 30; 68(12):2135-2143. PMID: 30357326.

    Read at: PubMed
  • Published on 5/17/2019

    Pelton SI, Bornheimer R, Doroff R, Shea KM, Sato R, Weycker D. Decline in Pneumococcal Disease Attenuated in Older Adults and Those With Comorbidities Following Universal Childhood PCV13 Immunization. Clin Infect Dis. 2019 05 17; 68(11):1831-1838. PMID: 30239637.

    Read at: PubMed
  • Published on 4/12/2019

    Pelton SI, Shea KM, Bornheimer R, Sato R, Weycker D. Pneumonia in young adults with asthma: impact on subsequent asthma exacerbations. J Asthma Allergy. 2019; 12:95-99. PMID: 31114255.

    Read at: PubMed
  • Published on 3/28/2019

    Barlam TF, Morgan JR, Kaplan WA, Outterson K, Pelton SI. Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship. J Pediatric Infect Dis Soc. 2019 Mar 28; 8(1):63-65. PMID: 28992176.

    Read at: PubMed
  • Published on 2/19/2019

    Mitchell PK, Azarian T, Croucher NJ, Callendrello A, Thompson CM, Pelton SI, Lipsitch M, Hanage WP. Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13. Microb Genom. 2019 02; 5(2). PMID: 30777813.

    Read at: PubMed

View 267 more publications: View full profile at BUMC

View all profiles